Results 11 to 20 of about 124,601 (306)

Primary diffuse large B-cell lymphoma of the breast [PDF]

Archive of Oncology, 2009
Primary breast lymphoma is rare location of this disease. Diffuse large B-cell lymphoma is the most common histological subtype. We presented two cases of primary diffuse large B-cell lymphoma of the breast and reviewed a literature about this topic.
Popović Lazar, Jovanović Darjana, Matovina-Brko Gorana, Petrović Dragana, Nikin Zoran, Roganović Tatjana   +5 more
doaj   +2 more sources

Two Cases of Pelvic Diffuse Large B-Cell Lymphoma [PDF]

Journal of Investigative Medicine High Impact Case Reports, 2022
Primary diffuse large B-cell lymphoma presenting as an extranodal site in the pelvis is rare and can mimic a gynecological malignancy. Although management for diffuse large B-cell lymphoma is standardized and curative, prognosis depends on timely ...
Rupam Sharma MD, Arash Heidari MD, Everardo Cobos MD, Greti Petersen MD, Amin A. Ramzan MD, Rahul D. Polineni MD   +5 more
doaj   +2 more sources

Pathophysiology and molecular aspects of diffuse large B-cell lymphoma

Revista Brasileira de Hematologia e Hemoterapia, 2012
Diffuse large B-Cell lymphoma is the most common subtype of non-Hodgkin lymphoma in the West. In Brazil, it is the fifth cause of cancer, with more than 55,000 cases and 26,000 deaths per year.
Gisele Rodrigues Gouveia, Sheila Aparecida Coelho Siqueira, Juliana Pereira   +2 more
doaj   +2 more sources

Intravascular diffuse large B-cell lymphoma with acquired ichthyosis: A case report

SAGE Open Medical Case Reports, 2023
Intravascular diffuse large B-cell lymphoma is an exceedingly rare subtype of B-cell lymphomas. This cancer is often associated with poor prognosis and can be lethal if left untreated.
Zainab Ridha, Hanieh Zargham, May Chergui, Elena Netchiporouk   +3 more
doaj   +1 more source

Low levels of monoclonal small B cells in the bone marrow of patients with diffuse large B-cell lymphoma of activated B-cell type but not of germinal center B-cell type

Haematologica, 2010
Background Multiparameter flow cytometry allows the detection of minor monoclonal B-cell populations. Using this technique combined with morphology, we were struck by the presence of minor populations of small monoclonal B cells in bone marrows of ...
Anne M. Tierens, Harald Holte, Abdirashid Warsame, Ida M. Ikonomou, Junbai Wang, Wing C. Chan, Jan Delabie   +6 more
doaj   +1 more source

Primary gastrointestinal diffuse large B-cell lymphoma: A prospective study from South India

South Asian Journal of Cancer, 2019
Background: Gastrointestinal tract (GIT) is the most common extranodal site for non-Hodgkin's lymphoma (NHL) and constitutes about 10%-15% of all NHL. This was a prospective study to evaluate the epidemiological, clinicopathological characteristics, and ...
Babu Suresh, Vikas Asati, K C Lakshmaiah, Govind Babu, D Lokanatha, Linu Abraham Jacob, K N Lokesh, A H Rudresh, L K Rajeev, Saldanha Smitha, Abhishek Anand, Rajesh Patidar, C S Premalata   +12 more
doaj   +1 more source

Composite Epstein-Barr virus-positive mucosa-associated lymphoid tissue lymphoma and Epstein-Barr virus-negative diffuse large B-cell lymphoma in the parotid salivary gland of a patient with Sjögren’s syndrome and rheumatoid arthritis: a case report

Journal of Medical Case Reports, 2020
Background Epstein-Barr virus is associated with many human hematopoietic neoplasms; however, Epstein-Barr virus-positive mucosa-associated lymphoid tissue lymphoma is extremely rare.
Vadim R. Gorodetskiy, Natalya A. Probatova, Dmitry M. Konovalov, Natalya V. Ryzhikova, Yulia V. Sidorova, Andrey B. Sudarikov, Olga V. Mukhortova   +6 more
doaj   +1 more source

Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs

Haematologica, 2017
Histone methylation and demethylation regulate B-cell development, and their deregulation correlates with tumor chemoresistance in diffuse large B-cell lymphoma, limiting cure rates. Since histone methylation status correlates with disease aggressiveness
Rohit Mathur, Lalit Sehgal, Ondrej Havranek, Stefan Köhrer, Tamer Khashab, Neeraj Jain, Jan A. Burger, Sattva S. Neelapu, R. Eric Davis, Felipe Samaniego   +9 more
doaj   +1 more source

Lenalidomide in Diffuse Large B-Cell Lymphomas [PDF]

Advances in Hematology, 2012
Diffuse Large B-cell Lymphomas (DLBCL) are the most frequent Non-Hodgkin Lymphomas (NHL). The addition of Rituximab to the standard chemotherapy CHOP improved the outcome in this patients, but so far 40% of patients experienced relapse or progressive disease.
Annalisa Chiappella, Umberto Vitolo
openaire   +3 more sources

Lenalidomide in Diffuse Large B-Cell Lymphoma [PDF]

Advances in Hematology, 2012
Diffuse large B-cell lymphoma (DLBCL) is the most common form of non-Hodgkin's lymphoma (NHL) in adults. Even if the natural history of DLBCL has been improved with the advent of immunochemotherapy, the survival results obtained with current treatment options clearly indicate that new agents or novel approaches are needed.
Catherine Thieblemont, Marie-Hélène Delfau-Larue, Bertrand Coiffier   +2 more
openaire   +3 more sources